CASIRIVIMAB AND IMDEVIMAB (Ronapreve®)

Clinical Indication

For patients hospitalised due to COVID-19

Date of classification

October 2021

Review date

October 2021

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.